REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

被引：0

作者：

Garris, C. ^{[1
]}

Dhir, S. ^{[1
]}

Waller, J. ^{[2
]}

Roberts, J. ^{[2
]}

Mycock, K. ^{[2
]}

Oglesby, A. ^{[1
]}

Collins, B. ^{[1
]}

Dominguez, M. ^{[1
]}

Pike, J. ^{[2
]}

Mrus, J. M. ^{[1
]}

机构：

[1] ViiV Healthcare, Res Triangle Pk, NC USA

[2] Adelphi Real World, Bollington, England

来源：

VALUE IN HEALTH | 2019年 / 22卷

关键词：

D O I：

10.1016/j.jval.2019.04.879

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PIN5

引用

页码：S195 / S195

页数：1

共 50 条

[21] Two-drug antiretroviral regimens for HIV
Thornhill, John P.
Cromarty, Ben
Gaddie, Jessica
Mushunje, Shiellah
Ferrand, Rashida A.
BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
[22] Using Climate-HIV to describe real-world clinical outcomes for people living with HIV on dolutegravir-based regimens
Okoli, C.
Schwenk, A.
Radford, M.
Myland, M.
Taylor, S.
van Wyk, J.
Barnes, J.
Fox, A.
Reeves, I.
Munshi, S.
Croucher, A.
Grimson, F.
Paice, A.
Boxall, N.
Darley, A. A.
Benn, P.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
[23] Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
Cattaneo, Dario
Sollima, Salvatore
Meraviglia, Paola
Milazzo, Laura
Minisci, Davide
Fusi, Marta
Filice, Carlo
Gervasoni, Cristina
DRUGS IN R&D, 2020, 20 (02) : 155 - 160
[24] Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
Dario Cattaneo
Salvatore Sollima
Paola Meraviglia
Laura Milazzo
Davide Minisci
Marta Fusi
Carlo Filice
Cristina Gervasoni
Drugs in R&D, 2020, 20 : 155 - 160
[25] Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence
Punekar, Y. S.
Parks, D.
Joshi, M.
Kaur, S.
Evitt, L.
Chounta, V
Radford, M.
Jha, D.
Ferrante, S.
Sharma, S.
Van Wyk, J.
de Ruiter, A.
HIV MEDICINE, 2021, 22 (06) : 423 - 433
[26] Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed
Borghetti, Alberto
Ciccullo, Arturo
Lombardi, Francesca
Giannarelli, Diana
Passerotto, Rosa Anna
Lamanna, Francesco
Carcagni, Antonella
Farinacci, Damiano
Dusina, Alex
Baldin, Gianmaria
Zazzi, Maurizio
Di Giambenedetto, Simona
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (05):
[27] Two-drug regimens for the treatment of HIV in Africa
Mambule, Ivan
Norcross, Claire
Ombajo, Loice Achieng
Sokhela, Simiso
Odongpiny, Eva Agnes Laker
Owarwo, Noela
Lawrence, David S.
Ruzagira, Eugene
Cresswell, Fiona, V
LANCET HIV, 2024, 11 (06): : e419 - e426
[28] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review
Rickesh Patel
Lee Evitt
Ilias Mariolis
Simona Di Giambenedetto
Antonella d’Arminio Monforte
José Casado
Alfonso Cabello Úbeda
Laurent Hocqueloux
Clotilde Allavena
Tristan Barber
Diwakar Jha
Rahul Kumar
Rahul Dinesh Kamath
Tia Vincent
Jean van Wyk
Justin Koteff
Infectious Diseases and Therapy, 2021, 10 : 2051 - 2070
[29] Real-world persistence of bictegravir- versus dolutegravir-based single tablet regimens in a large urban Canadian HIV centre
Knox, David
McCully, Jennifer
Smith, Graham S.
Mousadifar, Negin
Underhill, Angela
Saifi, Taban
Mumm, Dylana
Kovacs, Colin
Brunetta, Jason
Tsang, William
Acsai, Megan
Merkley, Barry
Giolma, Kevin
Fletcher, David
Cassidy, Tali
Navadeh, Soodi
Loutfy, Mona
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 109 - 110
[30] Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens
Okoli, Chinyere
Schwenk, Achim
Radford, Matthew
Myland, Melissa
Taylor, Stephen
Barnes, Justine
Fox, Ashini
Darley, Alison
Grimson, Fiona
Reeves, Iain
Munshi, Sajid
Croucher, Adam
Boxall, Naomi
Paice, Alistair
van Wyk, Jean
Benn, Paul
INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (12) : 1165 - 1173

← 1 2 3 4 5 →